NXG NexgenRx Inc.

0.6100CAD-4.69%Mkt Cap: 31.59M $P/E: 20.33

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims…

Key Statistics

Company
Market Cap31.59M USD
Enterprise Value31.95M USD
Revenue (TTM)14.09M USD
Gross Profit10.88M USD
Net Income (TTM)939.26K USD
Revenue/Share0.26 CAD
Last Price0.6100 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)20.33
P/E (Forward)—
PEG6.53
EV/EBITDA13.21
EV/Revenue2.27
P/S2.35
P/B5.87
EPS (TTM)0.03
EPS (Forward)—
52W Range
0.290070% of range0.7500
52W High0.7500 CAD
52W Low0.2900 CAD
Profitability
Gross Margin83.28%
Oper. Margin19.85%
EBITDA Margin17.18%
Profit Margin7.19%
ROE16.92%
ROA3.52%
Growth
Revenue Growth20.80%
Earnings Growth140.00%
Cash Flow & Leverage
Operating CF3.62M USD
CapEx (TTM)251.27K USD
FCF Margin9.35%
FCF Yield4.17%
Net Debt-2.40M USD
Net Debt/EBITDA-0.99
Balance Sheet
Debt/Equity0.05
Current Ratio1.15
Quick Ratio0.19
Book Value/Sh0.11 CAD
Cash/Share0.05 CAD
Dividends
Fwd Div Rate0.02 CAD
Trail. Div Rate0.01 CAD
Div. Yield3.13%
5Y Avg Yield2.53%
Payout Ratio48.39%
Ex-Div DateAug 28, 2026
Pay DateAug 31, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.12M
Float44.81M
Insiders36.98%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short1.75K
Short (prev mo.)416
Technical
SMA 500.6156 (-0.9%)
SMA 2000.4488 (+35.9%)
Beta0.49
S&P 52W Chg14.58%
Avg Vol (30d)19.05K
Avg Vol (10d)8.61K
Technical Indicators
RSI (14)50.3
MACD0.0078
MACD Signal0.0077
MACD Hist.+0.0001
BB Upper0.6587 CAD
BB Middle0.6160 CAD
BB Lower0.5733 CAD
BB Width13.88%
ATR (14)0.0266 CAD
Vol Ratio (20d)1.68x